India

Cough syrup deaths: PIL in SC seeks CBI Probe, nationwide drug safety review

The PIL requests that all pending FIRs and investigations concerning the deaths of children caused by toxic cough syrups across states be transferred to the CBI.

New Delhi: A PIL has been filed in the Supreme Court seeking inquiry and systemic reform in drug safety mechanisms in the wake of deaths of children in Madhya Pradesh and Rajasthan allegedly due to consumption of toxic cough syrups.

The PIL, filed by advocate Vishal Tiwari, seeks a court-monitored probe into the incidents and urges the constitution of a National Judicial Commission or Expert Committee headed by a retired Supreme Court judge.

The PIL requests that all pending FIRs and investigations concerning the deaths of children caused by toxic cough syrups across states be transferred to the CBI.

It seeks a probe under the supervision of a retired Supreme Court judge to ensure fairness and uniformity.

The petition contends that separate state-level investigations have led to fragmented accountability, enabling repeated lapses that allow hazardous formulations to reach the market.

The petition comes amid reports from Madhya Pradesh and Rajasthan, where several children allegedly died after consuming a particular kind of cough syrup.

The plea seeks court’s direction to the Central government to constitute a national-level judicial or expert body to identify the regulatory failures that allowed substandard medicines to reach the market.

It also urged the court to mandate toxicological testing of all suspect products through NABL-accredited laboratories before any further sale or export is permitted.

This post was last modified on October 7, 2025 2:11 pm

Share
Press Trust of India

Press Trust of India (PTI) is India’s premier news agency, having a reach as vast as the Indian Railways. It employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.

Load more...